摘要
抗体-毒素融合剂或免疫毒素,是一类新型的细胞毒性药物,由细菌或植物毒素组成,这些毒素与单克隆抗体或特定的生长因子连接在一起。然而,由于毛细血管渗漏综合征(CLS)是一种严重的免疫激发的、危及生命的副作用,导致内皮损伤,导致液体从血液中逃逸到肺、肌肉和脑等组织,发展器官衰竭,最终导致死亡,因此在临床上获得完全的效力受到限制。其潜在机制包括对内皮细胞的直接损伤、急性炎症、淋巴细胞活化杀伤(LAK)细胞的参与、细胞/细胞基质连接性的改变和细胞骨架功能障碍。肿瘤部位生物分布极差,外溢模式不均匀,导致肿瘤组织中邻近内皮细胞逐渐释放和启动,促炎性细胞因子的分泌,急性炎症的发展和淋巴因子激活杀伤细胞(LAK)的参与。应用毒素的固有免疫原性是CLS发病的另一个重要决定因素。具有较强内在免疫原性的毒素具有更大的发生CLS的可能性。近年来,具有保守细胞毒性的新一代抗体和突变毒素的开发,部分降低了CLS发展的风险。在此,我们描述了CLS的可能机制,并介绍了一些最近应用的尽可能减少CLS发病率的策略。
关键词: 血管渗漏综合征,免疫原性,细胞因子,免疫毒素,结合侧屏障,淋巴运动激活的杀伤细胞。
Current Molecular Medicine
Title:Probable Mechanisms Involved in Immunotoxin Mediated Capillary Leak Syndrome (CLS) and Recently Developed Countering Strategies
Volume: 18 Issue: 5
关键词: 血管渗漏综合征,免疫原性,细胞因子,免疫毒素,结合侧屏障,淋巴运动激活的杀伤细胞。
摘要: Antibody-toxin fused agents or immunotoxins, are a newly engineered class of cytotoxic agents consisting of a bacterial or plant toxin moiety hooked up either to a monoclonal antibody or a specific growth factor. Nevertheless, acquiring a full potency in clinic is mostly restricted due to the Capillary leak syndrome (CLS), a serious immune provoked, life-threatening side effect, subsequent to the endothelial damage, resulting in fluid escape from the bloodstream into tissues including lungs, muscle and brain, developing organ failure and eventually death. Proposed underlying mechanisms include direct damage to endothelial cells, acute inflammation, Lymphokine-activated killer (LAK) cells engagement, alteration in cell-cell/cell-matrix connectivities and cytoskeletal dysfunction. Very poor biodistribution and heterogeneous extravasation pattern in tumor site result in accumulation of ITs close to the extravasation site, gradual toxin release and initiation of nearby endothelial cells lysis, secretion of pro-inflammatory cytokines, development of acute inflammation and engagement of Lymphokine-activated killer (LAK) cells. Intrinsic immunogenicity of applied toxin moiety is another important determinant of CLS incidence. Toxins with more intrinsic immunogenicity possess more probability for CLS development. Recently, development of new generations of antibodies and mutated toxins with conserved cytotoxicity has partly tapered risk of CLS development. Here, we describe probable mechanisms involved in CLS and introduce some of the recently applied strategies for lessening incidence of CLS as much as possible.
Export Options
About this article
Cite this article as:
Probable Mechanisms Involved in Immunotoxin Mediated Capillary Leak Syndrome (CLS) and Recently Developed Countering Strategies, Current Molecular Medicine 2018; 18 (5) . https://dx.doi.org/10.2174/1566524018666181004120112
DOI https://dx.doi.org/10.2174/1566524018666181004120112 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia
Current Topics in Medicinal Chemistry The Application of Micro-Analytical Techniques to Biomedical Analysis
Current Pharmaceutical Analysis Coagulopathy as a Therapeutic Target for TRALI: Rationale and Possible Sites of Action
Current Pharmaceutical Design Herbal Folklore Medication for Liver Disorders
Current Traditional Medicine Shear Stress-sensitive Carriers for Localized Drug Delivery
Current Pharmaceutical Design The Oxygen Therapy
Current Medicinal Chemistry The Structure and Functions of P-Glycoprotein
Current Medicinal Chemistry New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design The Role of Catecholamines in Formation and Resolution of Pulmonary Oedema
Cardiovascular & Hematological Disorders-Drug Targets Management of Vasculopathy in Connective Tissue Disease
Current Rheumatology Reviews Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Diagnosis and Management of Hypertensive Emergencies Complicating Pregnancy
Current Women`s Health Reviews Soluble Adhesion Molecules in the Pathogenesis of Rheumatoid Arthritis
Current Pharmaceutical Design Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design Colloid Update
Current Pharmaceutical Design Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Current Trends in the Use of Cationic Polymer Assemblies for siRNA and Plasmid DNA Delivery
Pharmaceutical Nanotechnology Possible Exploitation of Non-Neuronal and Non-Chemical Synaptic Signalling Pathways in Epilepsy Therapy
Current Signal Transduction Therapy Immunotherapy of Melanoma
Current Molecular Pharmacology Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy